AVIR vs CTVA · $353.7M cap vs P/E 42, rev $16.91B
Atea Pharmaceuticals Inc (AVIR) versus Corteva Inc (CTVA) — a side-by-side from cached financials, not a winner call.
Atea Pharmaceuticals Inc (AVIR) is a biotechnology company listed on US.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
AVIR does not have a complete income-statement cache yet.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
AVIR currently screens at market cap $353.7M. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Not investment advice. Open the AVIR and CTVA stock pages for the full models.
Not investment advice.